{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:28:43Z","timestamp":1780093723414,"version":"3.54.0"},"reference-count":61,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Leslie and Michael Gaffin Foundation for Neuro-Oncology"},{"name":"Monse\u2019s Memorial Cancer Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Glioblastoma poses significant challenges in oncology, with bevacizumab showing promise as an antiangiogenic treatment but with limited efficacy. microRNAs (miRNAs) 10b and 21 have emerged as potential biomarkers for bevacizumab response in glioblastoma patients. This study delves into the expression dynamics of miR-21 and miR-10b in response to hypoxia and explores their circulation mechanisms. In vitro experiments exposed glioma cells (A172, U87MG, U251) and human umbilical vein endothelial cells (HUVEC) to hypoxic conditions (1% oxygen) for 24 h, revealing heightened levels of miR-10b and miR-21 in glioblastoma cells. Manipulating miR-10b expression in U87MG, demonstrating a significant decrease in VEGF alpha (VEGFA) following miR-10b overexpression under hypoxic conditions. Size exclusion chromatography illustrated a notable shift towards miR-21 and miR-10b exosomal packaging during hypoxia. A proposed model suggests that effective bevacizumab treatment reduces VEGFA levels, heightening hypoxia and subsequently upregulating miR-21 and miR-10b expression. These miRNAs, released via exosomes, might impact various cellular processes, with miR-10b notably contributing to VEGFA level reduction. However, post-treatment increases in miR-10b and miR-21 could potentially restore cells to normoxic conditions through the downregulation of VEGF. This study highlights the intricate feedback loop involving miR-10b, miR-21, and VEGFA in glioblastoma treatment, underscoring the necessity for personalized therapeutic strategies. Further research should explore clinical implications for personalized glioma treatments.<\/jats:p>","DOI":"10.3390\/ijms25147984","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T11:40:36Z","timestamp":1721734836000},"page":"7984","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Investigating Expression Dynamics of miR-21 and miR-10b in Glioblastoma Cells In Vitro: Insights into Responses to Hypoxia and Secretion Mechanisms"],"prefix":"10.3390","volume":"25","author":[{"given":"Hanna","family":"Charbit","sequence":"first","affiliation":[{"name":"Leslie and Michael Gaffin Center for Neuro-Oncology, Agnes Ginges Center for Human Neurogenetics, Department of Neurology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112002, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-1573","authenticated-orcid":false,"given":"Iris","family":"Lavon","sequence":"additional","affiliation":[{"name":"Leslie and Michael Gaffin Center for Neuro-Oncology, Agnes Ginges Center for Human Neurogenetics, Department of Neurology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112002, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrc2818","article-title":"Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma","volume":"10","author":"Huse","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1215\/S1152851704001115","article-title":"Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis","volume":"7","author":"Kaur","year":"2005","journal-title":"Neuro-Oncology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-018-0869-y","article-title":"Role of hypoxia-induced exosomes in tumor biology","volume":"17","author":"Shao","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia\u2014A key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: Molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<362::AID-CNCR20>3.0.CO;2-Z","article-title":"Microvessel density is a prognostic indicator for patients with astroglial brain tumors","volume":"77","author":"Leon","year":"1996","journal-title":"Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00234-015-1599-0","article-title":"High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: Tumor-associated neovascularization as a biomarker for patient survival. A preliminary study","volume":"58","author":"Puig","year":"2016","journal-title":"Neuroradiology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e14695","DOI":"10.1097\/MD.0000000000014695","article-title":"Prognostic role of microvessel density in patients with glioma","volume":"98","author":"Fan","year":"2019","journal-title":"Medicine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/annonc\/mdy106","article-title":"Bevacizumab may improve quality of life, but not overall survival in glioblastoma: An epidemiological study","volume":"29","author":"Gramatzki","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Monteiro, A.R., Hill, R., Pilkington, G.J., and Madureira, P.A. (2017). The Role of Hypoxia in Glioblastoma Invasion. Cells, 6.","DOI":"10.3390\/cells6040045"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2015.01.010","article-title":"Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1\u03b1-ZEB1 axis","volume":"359","author":"Joseph","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.cdd.4402310","article-title":"A microRNA component of the hypoxic response","volume":"15","author":"Kulshreshtha","year":"2008","journal-title":"Cell Death Differ."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00424-010-0910-5","article-title":"Invited review: Decoding the microRNA response to hypoxia","volume":"461","author":"Pocock","year":"2011","journal-title":"Pflug. Arch."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molcel.2009.09.006","article-title":"Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation","volume":"35","author":"Huang","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1128\/MCB.01276-10","article-title":"MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia","volume":"31","author":"Bruning","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/0008-5472.CAN-08-2516","article-title":"MicroRNA regulation of DNA repair gene expression in hypoxic stress","volume":"69","author":"Crosby","year":"2009","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"43475","DOI":"10.1074\/jbc.M111.284158","article-title":"Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)\/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1alpha-TWIST signaling networks in human breast cancer cells","volume":"286","author":"Haque","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1158\/0008-5472.CAN-10-3320","article-title":"HIF induces human embryonic stem cell markers in cancer cells","volume":"71","author":"Mathieu","year":"2011","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Neal, C.S., Michael, M.Z., Rawlings, L.H., Van der Hoek, M.B., and Gleadle, J.M. (2010). The VHL-dependent regulation of microRNAs in renal cancer. BMC Med., 8.","DOI":"10.1186\/1741-7015-8-64"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1038\/onc.2010.23","article-title":"Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs","volume":"29","author":"Yoshida","year":"2010","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1074\/jbc.M110.158790","article-title":"miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells","volume":"286","author":"Chan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lei, Z., Li, B., Yang, Z., Fang, H., Zhang, G.M., Feng, Z.H., and Huang, B. (2009). Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007629"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/MCB.01395-06","article-title":"A microRNA signature of hypoxia","volume":"27","author":"Kulshreshtha","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-11-0365","article-title":"Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation","volume":"71","author":"Polytarchou","year":"2011","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmed.2010.03.004","article-title":"MiR-210\u2014Micromanager of the hypoxia pathway","volume":"16","author":"Huang","year":"2010","journal-title":"Trends Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"155018","DOI":"10.1016\/j.prp.2023.155018","article-title":"The dual role of MiR-210 in the aetiology of cancer: A focus on hypoxia-inducible factor signalling","volume":"253","author":"Afsar","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/neuonc\/nos074","article-title":"MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity","volume":"14","author":"Teplyuk","year":"2012","journal-title":"Neuro-Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Liguori, G.L. (2024). Challenges and Promise for Glioblastoma Treatment through Extracellular Vesicle Inquiry. Cells, 13.","DOI":"10.3390\/cells13040336"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"S\u0142omka, A., Kornek, M., and Cho, W.C. (2022). Small Extracellular Vesicles and Their Involvement in Cancer Resistance: An Up-to-Date Review. Cells, 11.","DOI":"10.3390\/cells11182913"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ma, C., Nguyen, H.P.T., Jones, J.J., Stylli, S.S., Whitehead, C.A., Paradiso, L., Luwor, R.B., Areeb, Z., Hanssen, E., and Cho, E. (2022). Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052770"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mut, M., Adiguzel, Z., Cakir-Aktas, C., Hanalio\u011flu, \u015e., Gungor-Topcu, G., Kiyga, E., Isikay, I., Sarac, A., Soylemezoglu, F., and Strobel, T. (2023). Extracellular-Vesicle-Based Cancer Panels Diagnose Glioblastomas with High Sensitivity and Specificity. Cancers, 15.","DOI":"10.3390\/cancers15153782"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Galardi, A., De Bethlen, A., Di Paolo, V., Lampis, S., Mastronuzzi, A., and Di Giannatale, A. (2023). Recent Advancements on the Use of Exosomes as Drug Carriers for the Treatment of Glioblastoma. Life, 13.","DOI":"10.3390\/life13040964"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Jiang, H., Zhao, H., Zhang, M., He, Y., Li, X., Xu, Y., and Liu, X. (2022). Hypoxia Induced Changes of Exosome Cargo and Subsequent Biological Effects. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.824188"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.celrep.2020.01.073","article-title":"Glioma-Derived miRNA-Containing Extracellular Vesicles Induce Angiogenesis by Reprogramming Brain Endothelial Cells","volume":"30","author":"Lucero","year":"2020","journal-title":"Cell Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41374-020-00522-0","article-title":"Exosomes derived from hypoxic glioma deliver miR-1246 and miR-10b-5p to normoxic glioma cells to promote migration and invasion","volume":"101","author":"Qian","year":"2021","journal-title":"Lab. Investig. A J. Technol. Methods Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2012.08.003","article-title":"Cell-to-cell miRNA transfer: From body homeostasis to therapy","volume":"136","author":"Redis","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ben-Aicha, S., Badimon, L., and Vilahur, G. (2020). Advances in HDL: Much More than Lipid Transporters. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030732"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1093\/nar\/gkq601","article-title":"Export of microRNAs and microRNA-protective protein by mammalian cells","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3171\/2015.8.JNS15437","article-title":"Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab","volume":"125","author":"Siegal","year":"2016","journal-title":"J. Neurosurg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12032-019-1329-2","article-title":"The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: Perspectives for therapeutic implications","volume":"37","author":"Tamura","year":"2019","journal-title":"Med. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrrheum.2011.205","article-title":"Hypoxia\u2014A key regulator of angiogenesis and inflammation in rheumatoid arthritis","volume":"8","author":"Konisti","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature06174","article-title":"Tumour invasion and metastasis initiated by microRNA-10b in breast cancer","volume":"449","author":"Ma","year":"2007","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1618","article-title":"Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model","volume":"28","author":"Ma","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: An online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1126\/science.aav1741","article-title":"The biochemical basis of microRNA targeting efficacy","volume":"366","author":"McGeary","year":"2019","journal-title":"Science"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Jiang, F.S., Tian, S.S., Lu, J.J., Ding, X.H., Qian, C.D., Ding, B., Ding, Z.S., and Jin, B. (2015). Cardamonin Regulates miR-21 Expression and Suppresses Angiogenesis Induced by Vascular Endothelial Growth Factor. BioMed Res. Int., 2015.","DOI":"10.1155\/2015\/501581"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1369\/0022155415623515","article-title":"miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization Study","volume":"64","author":"Hermansen","year":"2016","journal-title":"J. Histochem. Cytochem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3171\/2016.3.JNS16523","article-title":"Letter to the Editor: MicroRNA levels and anti-VEGF therapy in glioblastoma","volume":"125","author":"Roesler","year":"2016","journal-title":"J. Neurosurg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1172\/JCI18420","article-title":"Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis","volume":"113","author":"Ozawa","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"F906","DOI":"10.1152\/ajprenal.00178.2017","article-title":"HIF-1-mediated production of exosomes during hypoxia is protective in renal tubular cells","volume":"313","author":"Zhang","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1074\/mcp.M900381-MCP200","article-title":"Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes","volume":"9","author":"Park","year":"2010","journal-title":"Mol. Cell. Proteom. MCP"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"King, H.W., Michael, M.Z., and Gleadle, J.M. (2012). Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-421"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1182\/blood-2014-05-576116","article-title":"Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1","volume":"124","author":"Umezu","year":"2014","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/mt.2015.72","article-title":"The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma","volume":"23","author":"Wong","year":"2015","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_59","unstructured":"Brun, V., and Cout\u00e9, Y. (2019). Serum Exosome Isolation by Size-Exclusion Chromatography for the Discovery and Validation of Preeclampsia-Associated Biomarkers. Proteomics for Biomarker Discovery: Methods and Protocols, Springer."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-017-1374-6","article-title":"Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma","volume":"16","author":"Stranska","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/bmb.21596","article-title":"A simple spreadsheet-based method for relative quantification using quantitative real-time PCR","volume":"50","author":"Ng","year":"2022","journal-title":"Biochem. Mol. Biol. Educ."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/14\/7984\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:20:56Z","timestamp":1760109656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/14\/7984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":61,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["ijms25147984"],"URL":"https:\/\/doi.org\/10.3390\/ijms25147984","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]}}}